PrPC-Mediated Ca²⁺/Calcineurin/TFEB Signaling Enhances Autophagic-Lysosomal Function and Anti-inflammatory Astrocyte Transition to Alleviate Cerebral Ischemia-Reperfusion Injury
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
An increasing number of studies have focused on understanding the role of macroautophagy/autophagy and the autophagy-lysosomal pathway (ALP) in cerebral ischemic injury. Transcription factor EB (TFEB) is a central regulator of genes involved in autophagy and plays a pivotal role in the regulation of the ALP; however, the mechanisms controlling TFEB activity remain incompletely understood. In this study, we investigated the role of cellular prion protein (PrPC)-targeted TFEB in mediating ALP dysfunction and inflammatory phenotypic changes in mouse cortical astrocytes after cerebral ischemia-reperfusion injury (CIRI). Our findings indicate that during the ultra-early phase of CIRI, intracellular Ca2+ levels are low, with inhibited PPP3/calcineurin activity and reactivation of mTOR, leading to TFEB phosphorylation and retention in the cytoplasm. As reperfusion time increases, elevated intracellular Ca2+ levels activate PPP3/calcineurin, resulting in TFEB dephosphorylation, nuclear translocation, and the subsequent induction of autophagy lysosome-associated gene transcription. This process promotes astrocyte survival and shifts the cellular phenotype toward an anti-inflammatory state. Furthermore, increased PrPC expression was observed to maintain intracellular Ca2+ homeostasis and sustain PPP3/calcineurin activation, facilitating continuous TFEB dephosphorylation and nuclear translocation. These results clarify the regulatory role of PrPC in astrocytic autophagy-lysosomal pathways following cerebral ischemia/reperfusion injury, providing new insights for more targeted interventions in ischemic stroke.